🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

109 results for “PRECISION BIOSCIENCES INC” Clear

  1. CD123 targeted CAR-NK cells

    PRECISION BIOSCIENCES INC

    Acute Myeloid Leukemia

    phase 2 mab active

    1 trial

  2. CD19 CAR-T cells

    PRECISION BIOSCIENCES INC

    Autoimmune Diseases

    phase 2 mab active

    1 trial

  3. CD19 CAR-T cells

    PRECISION BIOSCIENCES INC

    Leukemia

    phase 2 mab active

    2 trials

  4. CD19 and CD22 targeted CAR-T cells

    PRECISION BIOSCIENCES INC

    Leukemia, B-cell

    phase 2 mab active

    2 trials

  5. CD19 and CD22 targeted prime CAR- T cells

    PRECISION BIOSCIENCES INC

    B Cell Lymphoma

    phase 2 mab active

    1 trial

  6. CD19 and CD22 targeted prime CAR-T cells

    PRECISION BIOSCIENCES INC

    B-ALL

    phase 2 mab active

    1 trial

  7. CEA CAR-T cells

    PRECISION BIOSCIENCES INC

    Solid Tumor

    phase 2 mab active

    1 trial

  8. CEA-targeted CAR-T cells

    PRECISION BIOSCIENCES INC

    Gastric Cancer

    phase 2 mab active

    3 trials

  9. Gemcitabine

    PRECISION BIOSCIENCES INC

    Pancreatic Cancer, Adult

    phase 2 small molecule terminated

    1 trial

  10. Melphalan flufenamide (Melflufen)

    PRECISION BIOSCIENCES INC

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  11. NEO-201 in combination with pembrolizumab

    PRECISION BIOSCIENCES INC

    Non Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  12. NPC-1C/NEO-102

    PRECISION BIOSCIENCES INC

    Metastatic Pancreatic Cancer

    phase 2 small molecule completed

    1 trial

  13. NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)

    PRECISION BIOSCIENCES INC

    Soft Tissue Sarcoma

    phase 2 mab active

    1 trial

  14. OPM-101

    PRECISION BIOSCIENCES INC

    Advanced Melanoma

    phase 2 small molecule active

    1 trial

  15. PBCAR20A

    PRECISION BIOSCIENCES INC

    Non-Hodgkin's Lymphoma, Relapsed

    phase 2 gene therapy completed

    1 trial

  16. PBGENE-DMD (IV)

    PRECISION BIOSCIENCES INC

    Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD

    phase 2 mab active

    1 trial

  17. PCN-101

    PRECISION BIOSCIENCES INC

    Treatment Resistant Depression

    phase 2 small molecule completed

    1 trial

  18. PDI-192

    PRECISION BIOSCIENCES INC

    Atopic Dermatitis

    phase 2 small molecule completed

    1 trial

  19. PDI-320

    PRECISION BIOSCIENCES INC

    Rosacea

    phase 2 small molecule active

    1 trial

  20. PRAX-222 - Initial Dose

    PRECISION BIOSCIENCES INC

    SCN2A-DEE

    phase 2 small molecule active

    1 trial

  21. PRAX-628

    PRECISION BIOSCIENCES INC

    Focal onset seizures or primary generalized tonic-clonic seizures

    phase 2 small molecule active

    1 trial

  22. Part A: 20 and 40 mg PRAX-944

    PRECISION BIOSCIENCES INC

    Essential Tremor

    phase 2 small molecule completed

    1 trial

  23. delolimogene mupadenorepvec

    PRECISION BIOSCIENCES INC

    Malignant Melanoma

    phase 2 gene therapy completed

    1 trial

  24. donor-derived NK cell infusion

    PRECISION BIOSCIENCES INC

    Non-small Cell Lung Cancer

    phase 2 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources